Evidence map›Paper›PMID 38418987›Full record

ArticleBMC medical imaging2024

PulmoNet: a novel deep learning based pulmonary diseases detection model.

AbdulRahman Tosho Abdulahi, Roseline Oluwaseun Ogundokun, Ajiboye Raimot Adenike, Mohd Asif Shah, Yusuf Kola Ahmed

Open access · goldAbstract read
In one paragraph

Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 5 countries.

AbdulRahman Tosho AbdulahiDepartment of Computer Science, Institute of Information and Communication Technology, Kwara State Polytechnic, Ilorin, Nigeria.ORCID 0000-0003-2899-9883
Roseline Oluwaseun OgundokunDepartment of Multimedia Engineering, Kaunas University of Technology, Kaunas, Lithuania.ORCID 0000-0002-2592-2824
Ajiboye Raimot AdenikeDepartment of Statistics, Institute of Applied Sciences, Kwara State Polytechnic, Ilorin, Nigeria.ORCID 0000-0002-8344-2837
Mohd Asif ShahDepartment of Economics, Kebri Dehar University, Kebri Dehar, 250, Somali, Ethiopia. drmohdasifshah@kdu.edu.et.ORCID 0000-0002-0351-9559
Yusuf Kola AhmedDepartment of Biomedical Engineering, University of Ilorin, Ilorin, Nigeria.
Kwara State Polytechnic · NGAmhara Agricultural Research Institute · ETKaunas University of Technology · LTUniversity of Ilorin · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary diseases are various pathological conditions that affect respiratory tissues and organs, making the exchange of gas challenging for animals inhaling and exhaling. It varies from gentle and self-limiting such as the common cold and catarrh, to life-threatening ones, such as viral pneumonia (VP), bacterial pneumonia (BP), and tuberculosis, as well as a severe acute respiratory syndrome, such as the coronavirus 2019 (COVID-19). The cost of diagnosis and treatment of pulmonary infections is on the high side, most especially in developing countries, and since radiography images (X-ray and computed tomography (CT) scan images) have proven beneficial in detecting various pulmonary infections, many machine learning (ML) models and image processing procedures have been utilized to identify these infections. The need for timely and accurate detection can be lifesaving, especially during a pandemic. This paper, therefore, suggested a deep convolutional neural network (DCNN) founded image detection model, optimized with image augmentation technique, to detect three (3) different pulmonary diseases (COVID-19, bacterial pneumonia, and viral pneumonia). The dataset containing four (4) different classes (healthy (10,325), COVID-19 (3,749), BP (883), and VP (1,478)) was utilized as training/testing data for the suggested model. The model's performance indicates high potential in detecting the three (3) classes of pulmonary diseases. The model recorded average detection accuracy of 94%, 95.4%, 99.4%, and 98.30%, and training/detection time of about 60/50 s. This result indicates the proficiency of the suggested approach when likened to the traditional texture descriptors technique of pulmonary disease recognition utilizing X-ray and CT scan images. This study introduces an innovative deep convolutional neural network model to enhance the detection of pulmonary diseases like COVID-19 and pneumonia using radiography. This model, notable for its accuracy and efficiency, promises significant advancements in medical diagnostics, particularly beneficial in developing countries due to its potential to surpass traditional diagnostic methods.

Indexed as

COVID-19Deep LearningLung DiseasesPneumonia, BacterialPneumonia, ViralHumansSARS-CoV-2AccuracyCT scanDeep convolutional neural networkMachine learningPulmonary diseasesX-ray

Identifiers

PMID38418987
PMCPMC10903074
OpenAlexW4392241451

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.